Abiopharma

News list

Mahmood Nadir 🟢 acquired 240.0K shares (1 derivative) of Nkarta, Inc. (NKTX) at $1.93 Transaction Date: Jan 06, 2026 | Filing ID: 007897

Full text

News bot Jan. 8, 2026, 10:51 p.m.
🔍 Mahmood Nadir (Executive)

Company: Nkarta, Inc. (NKTX)

Report Date: 2026-01-06
Transaction Summary:
- Total transactions: 2
- Derivative instruments: 1
- Holdings reported: 0
- Total shares acquired: 240,000
Detailed Transactions and Holdings:
- Acquired 80,000 shares of Common Stock (Direct)
  Date: 2026-01-06 | Code: A | equity_swap_involved: false | shares_owned_after: 173,376.00 | transaction_form_type: 4 | Footnotes: F1
- Acquired 160,000 shares of Stock Option (right to buy) at $1.93 per share (Derivative)
  Date: 2026-01-06 | Code: A | Expires: 2036-01-05 | equity_swap_involved: false | shares_owned_after: 160,000.00 | transaction_form_type: 4 | Footnotes: F2
Footnotes:
- F1: Represents Restricted Stock Units ("RSUs") which vest in four equal annual installments beginning on January 14, 2027. Each RSU represents a contingent right to receive one share of Common Stock of the Issuer.
- F2: This option is scheduled to vest and become exercisable in 48 equal monthly installments occurring on the completion of each successive month of the Reporting Person's service to the Issuer following January 14, 2026.